BioPharma

Queen Mary’s medical and dentistry research is world famous.

Queen Mary Innovation 9 Pipeline 9 BioPharma

From the laboratory bench to public health initiatives, we’re at the forefront of innovation, finding solutions to the world’s greatest health challenges.

Explore our licencing opportunities and get in touch to discuss how we can work together to take these innovations from the lab to the market.

Digital Twin of the Aorta

BioPharma, Cardiovascular

Predicting Pre-Eclampsia

Diagnostics

Predicting responses to arthritis treatments

Therapeutics

Predicting dementia nine years before symptoms

BioPharma, Diagnostics

Enhancing the efficacy of immunotherapy in lung cancer

BioPharma, Oncology, Treatment

A Combination Therapy for Neovascular Eye Diseases

Angiogenesis, BioPharma, Treatment

Diagnosing type 1 diabetes using insulin neoepitopes

BioPharma, Diagnostics

Reversing tumour resistance to kinase inhibitors

BioPharma, Oncology, Therapeutics

Restorative treatments for osteoarthritis

BioPharma, Therapeutics

TREX: A novel method for isolating RNA-binding proteins

BioPharma

Using Resolvins to assess the risk of Cardiovascular Diseases

BioPharma, Cardiovascular, Therapeutics

Restoring Erythropoiesis in Myelodysplastic Syndrome

BioPharma, Therapeutics

Repurposing an anti-cancer agent to treat heart failure

BioPharma, Cardiovascular, Therapeutics

A Rapid PCR Test for Early Cancer Diagnosis

BioPharma, Diagnostics, Oncology

Inhibitors to target activated fibroblasts

BioPharma, Oncology

A new method for detecting circulating tumour cells

BioPharma, Oncology

A Peptide Therapy for Neovascular Eye Diseases

BioPharma, Therapeutics

Drug ranking using machine learning

BioPharma, Oncology, Therapeutics

Can’t find what you’re looking for?

Get in touch with our team or follow us on LinkedIn to stay up to date with our work.

Get in touch